Polecat's Industry Briefing Highlights (January 2026)

Energy Industry

Tensions between energy security and transition timelines are mounting. This is increasingly related to growing energy demand from data centres. Both governments and corporations are continuing, or revitalising, investment in fossil fuels. This coincides with wider investment in renewables; nuclear and offshore wind frameworks in Europe signal continued commitment to long-term decarbonisation, but uneven transition pacing highlights a complex and non-linear pathway to net zero.

Key Headlines:

1. UK Joins European Offshore Windfarm Plan to Create World's Largest "Clean Energy Reservoir"

2. Climate Activist Shareholder Group Pushes BP, Shell on Plans for Declining Oil Demand

3. Trump's Transformation Secretary Sean P. Duffy Unleashes American Energy, Awards Texas GulfLink First U.S. Deepwater Port License

AI Enablers

Concerns over the generation of non-consensual sexualised images of women, and in some cases children, have drawn increased attention to AI safety and intensified regulatory scrutiny across the sector. Meanwhile, ongoing discussions about AI’s significant water usage are increasingly framed through the lens of current human rights concerns. Though these conversations were largely overshadowed by user privacy debates throughout January and into early February. As AI continues to expand rapidly, geopolitical tensions surrounding rare earth materials are also rising, particularly as the United States, the European Union, Japan, Australia, and several Indo-Pacific economies are pursuing strategies to reduce dependence on China.

Key Headlines:

1. X Offices Raided in France as UK Opens Fresh Investigation into Grok

2. G7, Other Allies Discuss Ways to Reduce Dependence on Chinese Rare Earths

3. Trump Announces Creation of Critical Mineral Reserve

Pharmaceutical Industry

The narrative around the pharmaceutical industry has evolved from "pharmaceutical sector under pressure" to "pharmaceutical sector actively transforming amid pressure." While December highlighted pricing and affordability challenges, January shows that the industry has shifted from defensive positioning to aggressive strategic moves. The past month showed the pharmaceutical industry’s efforts to pursue massive M&A deals, double down on AI innovation (with smaller players like Deep EigenMatics outpacing incumbents), and make billion-dollar investments in partnerships with China. Regulatory fluctuation, however, remains and has intensified — with more dramatic swings between enforcement (UK, China) and deregulation (eased R&D norms, Green Lane approvals).

Key Headlines:

1. UK Industry Body Says Sanofi in Breach Over RSV Therapy Claims Against Pfizer

2. AstraZeneca Strengthens China Ties with Planned $15B Investment

3. Pharma Group Backs FDA's Green Lane for Faster Health Product Approval

Retail & FMCG 

As the industry moves from January to February, the retail industry continues to prioritise the consumer, with a focus on changing consumer trends and investments in personalising in-store shopping. At the same time, though, the retail/ FMCG industries are pivoting back to investing time and money into revolutionising distribution centers through technology. Lastly, January saw a revived focus on sustainability efforts within the industry, and increased competition when it comes to large, global brands.

Key Headlines:

1. PepsiCo Partners with Siemens and NVIDIA to Modernise Plants Using Digital Twins

2. The GLP-1 Gamble: Why Supermarkets are Selling Less for More

3. Enhance Sustainability Focus: Top Paper Packaging Products Manufacturer Expands Biodegradable Solutions